Standout Papers

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on va... 2004 2026 2011 2018 1.8k
  1. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2004)
    Stevo Julius, Sverre E. Kjeldsen et al. The Lancet

Immediate Impact

1 from Science/Nature 85 standout
Sub-graph 1 of 17

Citing Papers

Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
1 intermediate paper

Works of Steffan Ekman being referenced

Cardiovascular safety of the glucagon‐like peptide‐1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta‐analysis of randomized controlled trials
2015

Author Peers

Author Last Decade Papers Cites
Steffan Ekman 2551 1201 712 15 3.0k
Leanne Dyal 1867 1262 635 24 3.1k
Jean‐Pierre Boissel 1639 446 500 47 2.8k
Patrick Kesteven 922 758 277 50 3.3k
Esteban Linares 1736 1583 2002 6 3.8k
Maria Carla Roncaglioni 1456 782 773 97 3.6k
S. Westerling 3152 1668 785 6 4.0k
Peggy Gao 3021 725 1230 70 5.2k
Steven L. Zelenkofske 2865 645 620 29 4.0k
Ingrid Copland 2495 387 1183 8 2.7k
Jean‐Pierre Cambou 2501 1730 1028 73 4.0k

All Works

Loading papers...

Rankless by CCL
2026